Pawlak-Buś Katarzyna (Katarzyna Pawlak-Buś)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Clinical Practice

Disease Activity

Systemic Lupus Erythematosus

Top Venues

Journal of clinical medicine

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Schmidt Wiktor, Pawlak-Buś Katarzyna, Barbara Jóźwiak, Piotr Leszczyński
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience. Journal of clinical medicine 12 (6) (2023)
Schmidt Wiktor, Pawlak-Buś Katarzyna, Barbara Jóźwiak, Piotr Leszczyński
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience. Journal of clinical medicine 12 (6) (2023)
Schmidt Wiktor, Pawlak-Buś Katarzyna, Barbara Jóźwiak, Piotr Leszczyński
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience. Journal of clinical medicine 12 (6) (2023)
Pawlak-Buś Katarzyna, Schmidt Wiktor, Dudziec Ewa, Leszczyński Piotr
Current treatment of systemic lupus erythematosus: a clinician's perspective. Rheumatology international (2023)
Pawlak-Buś Katarzyna, Leszczyński Piotr
2022 Systemic lupus erythematosus remission in clinical practice. Message for Polish rheumatologists. Reumatologia 60 (2) (2022)
Marcin Stajszczyk, Sławomir Jeka, Anna Juś, Pawlak-Buś Katarzyna
Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients - the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response - results from the multicenter observational ACT-POL study. Reumatologia 60 (2) (2022)
Pawlak-Buś Katarzyna, Schmidt Wiktor, Piotr Leszczyński
Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus. Journal of clinical medicine 10 (20) (2021)